Robert E. Bellet
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 24
- Cancer Treatment and Pharmacology 10
- Cutaneous Melanoma Detection and Management 6
- Cancer Immunotherapy and Biomarkers 5
-
- Cancer therapeutics and mechanisms 4
- Melanoma and MAPK Pathways 3
- Co-authors
- Michael J. Mastrangelo (19 shared papers)David Berd (10 shared papers)R S Walters (2 shared papers)Vicente Valero (2 shared papers)Giuseppe Fraschini (2 shared papers)Leticia Esparza (1 shared paper)Richard L. Theriault (1 shared paper)Gabriel N. Hortobágyi (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer (5 papers)JNCI Journal of the National Cancer Institute (1 paper)European Journal of Cancer (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Robert E. Bellet
35 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 87
- Oncology 1.0k
- Cancer Research 349
- Dermatology 180
- Immunology 217
- Hematology 70
Countries citing papers authored by Robert E. Bellet
This map shows the geographic impact of Robert E. Bellet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Bellet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Bellet more than expected).
Fields of papers citing papers by Robert E. Bellet
This network shows the impact of papers produced by Robert E. Bellet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Bellet. The network helps show where Robert E. Bellet may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Bellet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 325 | |
| 2 | 1995 | 275 | |
| 3 | 1992 | 111 | |
| 4 | 1989 | 93 | |
| 5 | Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma. | 1987 | 81 |
| 6 | 1976 | 50 | |
| 7 | 1975 | 49 | |
| 8 | 1977 | 47 | |
| 9 | 1979 | 43 | |
| 10 | 1980 | 41 | |
| 11 | 2008 | 40 | |
| 12 | Phase I study of 5-azacytidine (NSC-102816) . | 1972 | 33 |
| 13 | 1977 | 32 | |
| 14 | 1973 | 28 | |
| 15 | 2007 | 16 | |
| 16 | 1977 | 16 | |
| 17 | 1993 | 14 | |
| 18 | 1999 | 13 | |
| 19 | Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study). | 1973 | 13 |
| 20 | 1987 | 13 |
About Robert E. Bellet
Robert E. Bellet is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Immunotherapy and Immune Responses (7 papers), Cutaneous Melanoma Detection and Management (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer therapeutics and mechanisms (4 papers), Chemotherapy-related skin toxicity (4 papers), Melanoma and MAPK Pathways (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (349 citations), Dermatology (180 citations), Immunology (217 citations) and Hematology (70 citations). Robert E. Bellet has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Michael J. Mastrangelo, David Berd, R S Walters, Vicente Valero, Giuseppe Fraschini, Leticia Esparza, Richard L. Theriault, Gabriel N. Hortobágyi, Aman U. Buzdar and Gustavo Fonseca. Their work appears in journals such as Journal of Clinical Oncology, Cancer, JNCI Journal of the National Cancer Institute, European Journal of Cancer and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.